Clinical Trial

A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The safety, tolerability, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics study of HEC169584 capsules in healthy subjects .
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-24.
Status change: Not Yet Recruiting → Recruiting 2026-04-24
Trial Details
NCT Number NCT07099118
Lead Sponsor Sunshine Lake Pharma Co., Ltd.
Conditions Non - Alcoholic Steatohepatitis
Enrollment 96 participants
Start Date 2025-09-03
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-03-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-27